330 related articles for article (PubMed ID: 8632315)
1. Characterization of the antinociceptive properties of cimetidine and a structural analog.
Li BY; Nalwalk JW; Barker LA; Cumming P; Parsons ME; Hough LB
J Pharmacol Exp Ther; 1996 Feb; 276(2):500-8. PubMed ID: 8632315
[TBL] [Abstract][Full Text] [Related]
2. Effects of naltrexone and histamine antagonists on the antinociceptive activity of the cimetidine analog SKF92374 in rats.
Li BY; Nalwalk JW; Hough LB
Brain Res; 1997 Feb; 748(1-2):168-74. PubMed ID: 9067458
[TBL] [Abstract][Full Text] [Related]
3. Role of the histamine system in nefopam-induced antinociception in mice.
Girard P; Pansart Y; Coppé MC; Verniers D; Gillardin JM
Eur J Pharmacol; 2004 Oct; 503(1-3):63-9. PubMed ID: 15496297
[TBL] [Abstract][Full Text] [Related]
4. Novel qualitative structure-activity relationships for the antinociceptive actions of H2 antagonists, H3 antagonists and derivatives.
Hough LB; Nalwalk JW; Li BY; Leurs R; Menge WM; Timmerman H; Carlile ME; Cioffi C; Wentland M
J Pharmacol Exp Ther; 1997 Dec; 283(3):1534-43. PubMed ID: 9400031
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the histamine receptors in the guinea-pig lung: evidence for relaxant histamine H3 receptors in the trachea.
Cardell LO; Edvinsson L
Br J Pharmacol; 1994 Feb; 111(2):445-54. PubMed ID: 7911715
[TBL] [Abstract][Full Text] [Related]
6. Evidence for histamine H1 and H2 receptors in guinea-pig oxyntic cells.
Vinik AI; Heldsinger AA; Skoglund ML
J Pharmacol Exp Ther; 1983 Oct; 227(1):115-21. PubMed ID: 6137553
[TBL] [Abstract][Full Text] [Related]
7. Studies on the pharmacology of the novel histamine H3 receptor agonist Sch 50971.
Hey JA; Aslanian R; Bolser DC; Chapman RW; Egan RW; Rizzo CA; Shih NY; Fernandez X; McLeod RL; West R; Kreutner W
Arzneimittelforschung; 1998 Sep; 48(9):881-8. PubMed ID: 9793613
[TBL] [Abstract][Full Text] [Related]
8. Action of ebrotidine, ranitidine and cimetidine on the specific binding to histamine H1- and H2-receptors.
Agut J; Sánchez JC; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):447-9. PubMed ID: 9205741
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of the novel histamine H3-receptor antagonist N-(3,5-dichlorophenyl)-N'-[[4-(1H-imidazol-4-ylmethyl)phenyl]-methyl]-urea (SCH 79687).
McLeod RL; Rizzo CA; West RE; Aslanian R; McCormick K; Bryant M; Hsieh Y; Korfmacher W; Mingo GG; Varty L; Williams SM; Shih NY; Egan RW; Hey JA
J Pharmacol Exp Ther; 2003 Jun; 305(3):1037-44. PubMed ID: 12649305
[TBL] [Abstract][Full Text] [Related]
10. Antinociceptive, brain-penetrating derivatives related to improgan, a non-opioid analgesic.
Hough LB; Nalwalk JW; Lu Q; Shan Z; Svokos K; Wentland MP; Montero MJ
Eur J Pharmacol; 2005 Oct; 522(1-3):38-46. PubMed ID: 16216240
[TBL] [Abstract][Full Text] [Related]
11. The role of histamine H1, H2 and H3 receptors on enteric ascending synaptic transmission in the guinea pig ileum.
Izzo AA; Costa M; Mascolo N; Capasso F
J Pharmacol Exp Ther; 1998 Dec; 287(3):952-7. PubMed ID: 9864278
[TBL] [Abstract][Full Text] [Related]
12. Development of chiral N-alkylcarbamates as new leads for potent and selective H3-receptor antagonists: synthesis, capillary electrophoresis, and in vitro and oral in vivo activity.
Sasse A; Kiec-Kononowicz K; Stark H; Motyl M; Reidemeister S; Ganellin CR; Ligneau X; Schwartz JC; Schunack W
J Med Chem; 1999 Feb; 42(4):593-600. PubMed ID: 10052966
[TBL] [Abstract][Full Text] [Related]
13. Effects of histamine, H1- and H2-receptor antagonists on the activity of serotonergic neurons in the dorsal raphe nucleus.
Lakoski JM; Aghajanian GK
J Pharmacol Exp Ther; 1983 Nov; 227(2):517-23. PubMed ID: 6138428
[TBL] [Abstract][Full Text] [Related]
14. In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent.
Benavides J; Schoemaker H; Dana C; Claustre Y; Delahaye M; Prouteau M; Manoury P; Allen J; Scatton B; Langer SZ
Arzneimittelforschung; 1995 May; 45(5):551-8. PubMed ID: 7612054
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonist.
Esbenshade TA; Fox GB; Krueger KM; Baranowski JL; Miller TR; Kang CH; Denny LI; Witte DG; Yao BB; Pan JB; Faghih R; Bennani YL; Williams M; Hancock AA
Biochem Pharmacol; 2004 Sep; 68(5):933-45. PubMed ID: 15294456
[TBL] [Abstract][Full Text] [Related]
16. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
Cavanagh RL; Usakewicz JJ; Buyniski JP
J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316
[TBL] [Abstract][Full Text] [Related]
17. The involvement of histamine H2-receptors in restraint-induced antinociception in male mice.
Wong CL
Methods Find Exp Clin Pharmacol; 1993; 15(6):351-6. PubMed ID: 7901462
[TBL] [Abstract][Full Text] [Related]
18. Analysis of an H1 receptor-mediated, zinc-potentiated vasoconstrictor action of the histidyl dipeptide carnosine in rabbit saphenous vein.
O'Dowd A; Miller DJ
Br J Pharmacol; 1998 Nov; 125(6):1272-80. PubMed ID: 9863657
[TBL] [Abstract][Full Text] [Related]
19. Characterization and development of cimetidine as a histamine H2-receptor antagonist.
Brimblecombe RW; Duncan WA; Durant GJ; Emmett JC; Ganellin CR; Leslie GB; Parsons ME
Gastroenterology; 1978 Feb; 74(2 Pt 2):339-47. PubMed ID: 23336
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological profile of new thioperamide derivatives at histamine peripheral H1-, H2-, H3-receptors in guinea-pig.
Barocelli E; Ballabeni V; Caretta A; Bordi F; Silva C; Morini G; Impicciatore M
Agents Actions; 1993 Mar; 38(3-4):158-64. PubMed ID: 8213342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
